Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 5 von 74
Frontiers in pharmacology, 2020-01, Vol.10, p.1625-1625
2020
Volltextzugriff (PDF)

Details

Autor(en) / Beteiligte
Titel
UPLC-Q-TOF-MS Study of the Mechanism of THSWD for Breast Cancer Treatment
Ist Teil von
  • Frontiers in pharmacology, 2020-01, Vol.10, p.1625-1625
Ort / Verlag
Switzerland: Frontiers Media S.A
Erscheinungsjahr
2020
Quelle
EZB Electronic Journals Library
Beschreibungen/Notizen
  • Taohong Siwu decoction (THSWD) is a classic traditional Chinese medicine (TCM) prescription that is widely used in the clinical treatment of gynecological and cerebrovascular diseases. Here we used a method that coupled ultra-performance liquid chromatography to quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF-MS) in which both positive and negative ion modes were established to investigate the major constituents in THSWD. A Waters ACQUITY UPLC BEH C18 column (2.1 mm×100 mm, 1.7 μm) was used to separate the aqueous extract of THSWD. The mobile phase consisted of 0.1% aqueous formic acid (A) and acetonitrile (B). Ninety-five components were identified in two different ion modes, including aromatic acids, flavones, polysaccharides, volatile oils monoterpene glycosides, aromatic cyanogenic glycosides, and others. Pathological changes in tumors and serum expression of interleukin-4 in a mouse model of breast cancer were detected after THSWD treatment. The results showed that THSWD had obvious therapeutic effects. This study establishes a material basis for the use of THSWD in the treatment of breast cancer.
Sprache
Englisch
Identifikatoren
ISSN: 1663-9812
eISSN: 1663-9812
DOI: 10.3389/fphar.2019.01625
Titel-ID: cdi_doaj_primary_oai_doaj_org_article_d37367f4b8e14208a194796c5610302d

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX